Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0782
    -0.0012 (-0.11%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2627
    +0.0005 (+0.04%)
     
  • USD/JPY

    151.3340
    -0.0380 (-0.03%)
     
  • Bitcoin USD

    70,036.88
    -781.73 (-1.10%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Top Research Reports on Walmart, NVIDIA and Procter & Gamble

Tilly's (TLYS) closed the most recent trading day at $16.18, moving -0.98% from the previous trading session.

Monday, November 20, 2017

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT), NVIDIA (NVDA) and Procter & Gamble (PG). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Buy-rated Walmart’s shares have been strong performers lately, with the stock up +24.1% over the last six months, outperforming the S&P 500's +7.8% gain in the same time period. The Zacks analyst likes Walmart’s solid earnings and comps record. The company has been gaining from constant e-commerce initiatives, like buyouts, alliances, and improved delivery systems.

These trends, along with solid traffic drove Walmart’s third-quarter fiscal 2018 performance, wherein both earnings and revenues rose year over year and beat estimates. Notably, this marked Walmart’s ninth and 13th straight quarter of positive earnings surprise and U.S. comps growth, respectively.

Also, the company’s international performance gained from strength in food categories. All these factors encouraged management to raise its view. However, stiff competition from brick and mortar and online retailers remains a concern. Also, macroeconomic woes like volatile consumer spending poses threats.

(You can read the full research report on Walmart here >>>).

Shares of Strong Buy-rated NVIDIA have surged over the last year, gaining in excess of +127.4% versus the Zacks Semiconductor - General industry’s +52% gain. NVIDIA posted impressive third-quarter fiscal 2018 results and provided encouraging fourth quarter revenue guidance.

Also, the company registered year-over-year growth on both counts, primarily due to growth across all its four platforms. Better-than-expected demand for gaming chips helped the company post encouraging results.

The Zacks analyst likes NVIDIA’s sustained efforts toward attaining robust position in several emerging industries such as Artificial Intelligence (AI), deep learning and driverless cars. NVIDIA’s innovative product pipeline and strength in gaming and high-end notebook GPUs remain the positives. The company’s focus on GRID platforms can increase GPU adoption in data centers, giving it an advantage against its competitors.

(You can read the full research report on NVIDIA here >>>).

Procter & Gamble's shares have underperformed the Zacks Soap and Cleaning Materials industry so far this year (+5.2% vs. +14.2%). P&G reported first-quarter fiscal 2018 results, wherein earnings and revenues surpassed expectations. Adjusted earnings increased 6% from the year-ago level aided by productivity cost savings.

Overall organic sales were up 1%, comprising 1% volume growth despite decelerating market growth and a 30 bps headwind from natural disasters. The Zacks analyst likes the company’s focus on balanced growth through improved product, packaging, and marketing initiatives and its productivity cost saving plan.

However, core gross and operating margin weakness was notable in the quarter that decreased 40 bps each. Lower pricing, higher commodity costs, increased competition and an unfavorable mix continued to hurt profitability. Again, decelerating organic sales growth in developed and developing markets raise concerns.

(You can read the full research report on Procter & Gamble here >>>).

Other noteworthy reports we are featuring today include Mondelez (MDLZ), Phillips 66 (PSX) and AstraZeneca (AZN).

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Mark Vickery

Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

Solid E-Commerce Efforts to Fuel Walmart's (WMT) Top-Line

NVIDIA (NVDA) Rides on AI Partnerships and Product Refreshes

Procter & Gamble's (PG) Cost Saving Plan Impresses, Sales Weak

Featured Reports

Ross Stores' (ROST) Sturdy Comps Run to Propel Top-Line

Ross Stores boasts impressive comparable sales run. Per the Zacks analyst, the company's better price management, merchandise, cost containment and operational initiatives should drive sales.

Exelon (EXC) to Gain from $20B Investments and Cost Savings

The Zacks analyst believes Exelon will gain from its continuous investment to strengthen its regulated assets, while its cost savings initiatives will boost its margins.

Mondelez (MDLZ) Strong on Power Brands, Volume Trend Weak

The covering analyst stresses that Power Brands has significantly contributed to Mondelez's revenue growth. However, the company's volume trends remain weak owing to sluggish demand.

Improving Trading Activity Benefits TD Ameritrade (AMTD)

The Zacks analyst believes TD Ameritrade is poised to growth through improving trading activities as DARTs continue to rise. Moreover, increase in revenue and easing margin pressure is favorable.

AstraZeneca (AZN) New Drugs Boost Sales Amid Generic Woes

Per the Zacks analyst, AstraZeneca's newer drugs like Tagrisso and Brilinta should keep boosting the top line.

Phillips 66 (PSX) Banks on Chemicals Business, Debts High

Rising debt load and declining cash balance are serious concerns, per the Zacks analyst.

CME (CME) Gains from Higher Clearing and Transaction Fees

Per the Zacks analyst, CME Group gains from higher clearing and transaction fees and volume growth.

New Upgrades

Netflix (NFLX) Benefits from Strong Content Portfolio

Per the Zacks analyst, Netflix continues to benefit from its ever expanding portfolio of original content. Emphasis on regional content will boost its international subscriber base.

RH's (RH) Acquisition & Membership Business Model Bodes Well

The Zacks analyst stresses that RH's membership business model and waterworks acquisition has enhanced the company's brand value and profitability.

International Revenue Growth, Debt Cuts Buoy Viacom (VIAB)

The Zacks analyst appreciates the strong growth in advertising and affiliate revenues on the international front. Efforts to reward shareholders and bring down its debt levels also raise optimism.

New Downgrades

Supply Delays, Soft U.S. Market to Hurt Zimmer Biomet (ZBH)

Per the Zacks analyst, Zimmer Biomet is grappling with supply delays, leading to the inability to recapture lost customers and gain new ones. Soft domestic market conditions is another concern.

Operational Challenges in Syncrude To Hurt Suncor (SU)

Poor operating history and frequent unplanned outages in the Syncrude project have hiked its near-term operating costs, which might hurt Suncor's earnings.

Weak Mining, Aerospace to Restrain ITT's (ITT) Momentum

Per the Zacks analyst, ITT's growth might be hampered due to weak mining activity, restrained client spending and softness in aerospace & defense market. Also, rising commodity costs remain a concern.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Wal-Mart Stores, Inc. (WMT) : Free Stock Analysis Report
 
Phillips 66 (PSX) : Free Stock Analysis Report
 
Procter & Gamble Company (The) (PG) : Free Stock Analysis Report
 
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
 
Mondelez International, Inc. (MDLZ) : Free Stock Analysis Report
 
Astrazeneca PLC (AZN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement